Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial
J. Guigay(Centre Antoine Lacassagne), Franck Darloy, S. Chapet(Hôpital de la Croix-Rousse), L. Bozec Le Moal, Sarah BETRIAN-LAGARDE, Alison Johnson(Centre François Baclesse), Sandrine Pacquelet(Scripps Research Institute), G. Calais, Christian Borel(Centre Hospitalier de Bretagne Sud), Alexandre CORNELLY, Brigitte Laguerre(Centre Eugène Marquis), H. Castanie, Fanny Louat(Groupe d'Oncologie Radiothérapie Tête et Cou), Laura Sinigaglia(Groupe d'Oncologie Radiothérapie Tête et Cou), Jean‐Pierre Delord, Jérôme Fayette(Hospices Civils de Lyon), Emmanuel Blot, Damien Vansteene(Institut de Cancérologie de l'Ouest), Miren Taberna(Institut Català d'Oncologia), Ricard Mesı́a(Institut d'Investigació Biomédica de Bellvitge), G. Béra, Camille Evrard(Université de Poitiers), Sophie Duplomb(Hôpital de la Croix-Rousse), Cécile Chevassus-Clément(Inserm), Amandine Bruyas, Pierre Dalloz(Institut Claudius Regaud), Mohamed BOUCHEKOUA, Philippe Schafhausen(University Medical Center Hamburg-Eppendorf), Sylvie Zanetta(Centre Georges François Leclerc), Oana Cojocarasu, Thierry Chatellier, Florian Clatot, Nabil Baba-Hamed, Ulrich Keilholz(Berliner Hochschule für Technik), E. Babin, Jean Bourhis, Aldéric Fraslin(Inserm), Emmanuelle Bompas, Laurent Martin(Groupe Hospitalier du Havre), Lionnel Geoffrois(Institut de Cancérologie de Lorraine), Ioana Carpiuc, Didier Cupissol(Institut de Recherche en Cancérologie de Montpellier), Anne Aupérin(Université de Montpellier), Christian Sire(Centre Hospitalier de Bretagne Sud), Bruno Chauffert(Centre Hospitalier de Saint-Quentin), Esma Saâda-Bouzid(Université Côte d'Azur), Caroline Even(Institut Gustave Roussy), Olivier Capitain(Institut de Cancérologie de l'Ouest), Cédrik Lafond(Centre Jean Bernard), Alexandre Coutté
Cited by 231
Related Papers
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
|New England Journal of Medicine|2006|2.7k
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2010|1.9k
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
|Head & Neck|2005|1.8k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
|Journal of Clinical Oncology|2010|806